Redhill Biopharma Ltd (NASDAQ:RDHL)

7.02
Delayed Data
As of Apr 12
 -0.31 / -4.24%
Today’s Change
5.93
Today|||52-Week Range
11.52
-13.12%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 21.00, with a high estimate of 26.00 and a low estimate of 12.00. The median estimate represents a +199.15% increase from the last price of 7.02.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.42
Sales
$22.6M
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 31.38%
 
 
 
 
 
 
Growthannually 45.84%
 
 
 
 
 
 

Sales

Growthquarterly 5.28%
 
 
 
 
 
 
Growthannually 91.47%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.